{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:22:24Z","timestamp":1792081344733,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2003,1,2]],"date-time":"2003-01-02T00:00:00Z","timestamp":1041465600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1038\/sj.npp.1300157","type":"journal-article","created":{"date-parts":[[2003,5,7]],"date-time":"2003-05-07T15:34:40Z","timestamp":1052321680000},"page":"995-1003","source":"Crossref","is-referenced-by-count":284,"title":["Atypical and Conventional Antipsychotic Drugs in Treatment-Naive First-Episode Schizophrenia: A 52-Week Randomized Trial of Clozapine Vs Chlorpromazine"],"prefix":"10.1038","volume":"28","author":[{"given":"Jeffrey A","family":"Lieberman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Stroup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongfu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M","family":"Hamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,1,2]]},"reference":[{"key":"BF1300157_CR1","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","volume":"156","author":"DB Allison","year":"1999","unstructured":"Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC et al (1999). Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156: 1686\u20131696.","journal-title":"Am J Psychiatry"},{"key":"BF1300157_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1192\/bjp.177.3.207","volume":"177","author":"TR Barnes","year":"2000","unstructured":"Barnes TR, Hutton SB, Chapman MJ, Mutsatsa S, Puri BK, Joyce EM (2000). West London first-episode study of schizophrenia: clinical correlates of duration of untreated psychosis. Br J Psychiatry 177: 207\u2013211.","journal-title":"Br J Psychiatry"},{"key":"BF1300157_CR3","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1176\/appi.ajp.157.5.808","volume":"157","author":"H Beng-Choon","year":"2000","unstructured":"Beng-Choon H, Andreassen NC, Flaum M, Nopoulos P, Miller D (2000). Untreated initial psychosis: its relation to quality of life and symptom remission in first episode schizophrenia. Am J Psychiatry 157: 808\u2013815.","journal-title":"Am J Psychiatry"},{"key":"BF1300157_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1001\/archpsyc.1996.01830040049009","volume":"53","author":"MH Chakos","year":"1996","unstructured":"Chakos MH, Alvir JMJ, Woerner MG, Koreen A, Geisler S, Mayerhoff D et al (1996). Incidence and correlates of tardive dyskinesia in first episode of schizophrenia. Arch Gen Psychiatry 53: 313\u2013319.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300157_CR5","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1176\/appi.ajp.158.4.518","volume":"158","author":"M Chakos","year":"2001","unstructured":"Chakos M, Lieberman JA, Hoffman E, Bradford D, Sheitman B (2001). Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry 158: 518\u2013526.","journal-title":"Am J Psychiatry"},{"key":"BF1300157_CR6","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1176\/ajp.152.12.1724","volume":"152","author":"A Chatterjee","year":"1995","unstructured":"Chatterjee A, Chakos M, Koreen A, Geisler S, Sheitman B, Alvir J et al (1995). Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesias in never medicated schizophrenic patients. Am J Psychiatry 152: 1724\u20131729.","journal-title":"Am J Psychiatry"},{"key":"BF1300157_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1176\/ajp.157.1.60","volume":"157","author":"TJ Craig","year":"2000","unstructured":"Craig TJ, Bromet EJ, Fennig S, Tanenberg-Karant M, Lavelle J, Galambos N (2000). Is there an association between duration of untreated psychosis and 24 month clinical outcome in a first admission series? Am J Psychiatry 157: 60\u201366.","journal-title":"Am J Psychiatry"},{"key":"BF1300157_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1192\/bjp.148.2.120","volume":"148","author":"TJ Crow","year":"1986","unstructured":"Crow TJ, MacMillan JF, Johnson AL, Johnstone EC (1986). A randomized controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry 148: 120\u2013127.","journal-title":"Br J Psychiatry"},{"key":"BF1300157_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/oxfordjournals.schbul.a033413","volume":"25","author":"RA Emsley","year":"1999","unstructured":"Emsley RA (1999). Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study. Schizophr Bull 25: 721\u2013729.","journal-title":"Schizophr Bull"},{"key":"BF1300157_CR10","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1136\/bmj.321.7273.1371","volume":"321","author":"J Geddes","year":"2000","unstructured":"Geddes J, Freemantle N, Bebbington P (2000). Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. Br Med J 321: 1360\u20131361.","journal-title":"Br Med J"},{"key":"BF1300157_CR11","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1176\/ajp.151.10.1409","volume":"151","author":"JD Hegarty","year":"1994","unstructured":"Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G (1994). One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry 151: 1409\u20131416.","journal-title":"Am J Psychiatry"},{"key":"BF1300157_CR12","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1176\/appi.ajp.157.6.975","volume":"157","author":"DC Henderson","year":"2000","unstructured":"Henderson DC, Cagliero E, Gray C, Nasrallah RA, Hayden DL, Schoenfeld DA et al (2000). Clozapine, diabetes mellitus, weight gain and lipid abnormalities: a five year naturalistic study. Am J Psychiatry 157: 975\u2013981.","journal-title":"Am J Psychiatry"},{"issue":"Suppl","key":"BF1300157_CR13","first-page":"4","volume":"154","author":"MI Herz","year":"1997","unstructured":"Herz MI, Liberman RP, Lieberman JA, Marder SR, McGlashan TH, Wyatt RJ et al (1997). Practice guidelines for the treatment of patients with schizophrenia. Am J Psychiatry 154(Suppl): 4.","journal-title":"Am J Psychiatry"},{"key":"BF1300157_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0920-9964(01)00237-7","volume":"51","author":"JO Johannesen","year":"2001","unstructured":"Johannesen JO, McGlashan TH, Larsen TK, Horneland M, Joa I, Mardal S et al (2001). Early detection strategies for untreated first-episode psychosis. Schizophr Res 51: 39\u201346.","journal-title":"Schizophr Res"},{"key":"BF1300157_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/BF02245602","volume":"124","author":"BJ Kinon","year":"1996","unstructured":"Kinon BJ, Lieberman JA (1996). Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology 124: 2\u201334.","journal-title":"Psychopharmacology"},{"key":"BF1300157_CR16","volume-title":"Dementia Praecox and Paraphrenia","author":"E Kraeplin","year":"1919","unstructured":"Kraeplin E (1919). Dementia Praecox and Paraphrenia. E&S Livingstone: Edinburgh, Scotland."},{"key":"BF1300157_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0920-9964(98)00105-4","volume":"35","author":"S Leucht","year":"1999","unstructured":"Leucht S, Pitschel-Walz G, Abraham D, Kissling W (1999). Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. Schizophr Res 35: 51\u201368.","journal-title":"Schizophr Res"},{"key":"BF1300157_CR18","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/archpsyc.1993.01820170047006","volume":"50","author":"J Lieberman","year":"1993","unstructured":"Lieberman J, Jody D, Geisler S, Alvir J, Loebel A, Szymanski S et al (1993). Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry 50: 369\u2013376.","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl 11","key":"BF1300157_CR19","first-page":"68","volume":"57","author":"JA Lieberman","year":"1996","unstructured":"Lieberman JA (1996). Atypical antipsychotic drugs as a first-line treatment of schizophrenia: a rationale and hypothesis. J Clin Psychiatry 57(Suppl 11): 68\u201371.","journal-title":"J Clin Psychiatry"},{"key":"BF1300157_CR20","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1097\/00004714-199804001-00005","volume":"18","author":"JA Lieberman","year":"1998","unstructured":"Lieberman JA, Sheitman B, Chakos M, Robinson D, Schooler N, Keith S (1998). The development of treatment resistance in patients with schizophrenia: a clinical and pathophysiological perspective. J Clin Psychopharmacol 18: S20\u2013S24.","journal-title":"J Clin Psychopharmacol"},{"key":"BF1300157_CR21","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1176\/ajp.149.9.1183","volume":"149","author":"AD Loebel","year":"1992","unstructured":"Loebel AD, Lieberman JA, Alvir JMJ, Mayerhoff DI, Geisler SH, Szymanski SR (1992). Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 149: 1183\u20131188.","journal-title":"Am J Psychiatry"},{"key":"BF1300157_CR22","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/archpsyc.1991.01810320063009","volume":"48","author":"JP McEvoy","year":"1991","unstructured":"McEvoy JP, Hogarty GE, Steingard S (1991). Optimal dose of neuroleptic in acute schizophrenia. Arch Gen Psychiatry 48: 739\u2013745.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300157_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/schbul\/14.4.515","volume":"14","author":"TH McGlashan","year":"1988","unstructured":"McGlashan TH (1988). A selective review of recent North American long-term follow-up studies of schizophrenia. Schizophr Bull 14: 515\u2013542.","journal-title":"Schizophr Bull"},{"key":"BF1300157_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1017\/S0033291701003488","volume":"31","author":"RM Norman","year":"2001","unstructured":"Norman RM, Malla AK (2001). Duration of untreated psychosis: a critical examination of the concept and its importance. Psychol Med 31: 381\u2013400.","journal-title":"Psychol Med"},{"key":"BF1300157_CR25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.31887\/DCNS.2001.3.2\/mrphillips","volume":"3","author":"M Phillips","year":"2001","unstructured":"Phillips M (2001). Characteristics, experience and treatment of schizophrenia in China. Dialog Clin Neurosci 3: 109\u2013119.","journal-title":"Dialog Clin Neurosci"},{"key":"BF1300157_CR26","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1600-0447.1991.tb03161.x","volume":"84","author":"MR Phillips","year":"1991","unstructured":"Phillips MR, Xiong W, Wang RW, Gao RH, Wang XQ, Zhang NP (1991). Reliability and validity of the Chinese versions of the scales for assessment of positive and negative symptoms. Acta Psychiatr Scand 84: 364\u2013370.","journal-title":"Acta Psychiatr Scand"},{"key":"BF1300157_CR27","volume-title":"Issues Involved in the Use of Scales for the Assessment of Negative and Positive Symptoms in Psychotic Patients","author":"MR Phillips","year":"1990","unstructured":"Phillips MR, Xiong W, Zhao ZA (1990). Issues Involved in the Use of Scales for the Assessment of Negative and Positive Symptoms in Psychotic Patients. Hubei Science and Technology Publishing House: Wuhan, PRC (in Chinese)."},{"key":"BF1300157_CR28","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1176\/ajp.156.10.1659","volume":"156","author":"D Robinson","year":"1999","unstructured":"Robinson D, Woerner M, Alvir J, Bilder R, Goldman R, Geisler S et al (1999). Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 156: 544\u2013549.","journal-title":"Am J Psychiatry"},{"key":"BF1300157_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1176\/ajp.156.1.79","volume":"156","author":"TM Sanger","year":"1999","unstructured":"Sanger TM, Lieberman JA, Tohen M, Grundy S, Beasley C, Tollefson GD (1999). Olanzapine versus haloperidol treatment in first-episode psychosis. Am J Psychiatry 156: 79\u201387.","journal-title":"Am J Psychiatry"},{"key":"BF1300157_CR30","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/schbul\/23.4.653","volume":"23","author":"BB Sheitman","year":"1997","unstructured":"Sheitman BB, Lee H, Strous R, Lieberman JA (1997). The evaluation and treatment of first episode psychoses. Schizophr Bull 23: 653\u2013661.","journal-title":"Schizophr Bull"},{"key":"BF1300157_CR31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1176\/ajp.153.4.519","volume":"153","author":"SR Szymanski","year":"1996","unstructured":"Szymanski SR, Cannon TD, Gallacher F, Erwin RJ, Gur RE (1996). Course and treatment response in first-episode and chronic schizophrenia. Am J Psychiatry 153: 519\u2013525.","journal-title":"Am J Psychiatry"},{"key":"BF1300157_CR32","first-page":"19","volume":"2","author":"B Wu","year":"1995","unstructured":"Wu B, Wu JP (1995). Investigation of antipsychotic use in hospitalized patients. Appl Psychiatry 2: 19\u201322 (in Chinese).","journal-title":"Appl Psychiatry"},{"key":"BF1300157_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0920-9964(91)90073-Z","volume":"5","author":"RJ Wyatt","year":"1999","unstructured":"Wyatt RJ (1999). Early intervention with neuroleptcis may decrease the long-term morbidity of schizophrenia. Schizophr Res 5: 201\u2013202.","journal-title":"Schizophr Res"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300157.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300157","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300157.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T18:22:10Z","timestamp":1704824530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1,2]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["BF1300157"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300157","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1,2]]}}}